Paloma Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Paloma Partners’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-18,215	Closed	-$139K	–	2677
2020 Q2	$139K	Buy	+18,215	New	+$139K	﹤0.01%	1823
2020 Q1	–	Sell	-34,512	Closed	-$420K	–	2353
2019 Q4	$420K	Buy	+34,512	New	+$377K	0.01%	1512
2019 Q3	–	Sell	-39,539	Closed	-$395K	–	2418
2019 Q2	$395K	Buy	+39,539	New	+$427K	0.01%	1158
2017 Q1	–	Sell	-19,970	Closed	-$695K	–	2348
2016 Q4	$695K	Buy	+19,970	New	+$597K	0.01%	1371

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Paloma Partners's AMAG Position: Q3 2020 in Review

Paloma Partners sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 18,215 shares — an estimated $139K sold.

Paloma Partners first reported a position in AMAG in Q4 2016 and held it in 4 quarters. The position peaked at $695K in Q4 2016. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.

Paloma Partners reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Paloma Partners sold 18,215 AMAG Pharmaceuticals shares in Q3 2020, an estimated $139K.
Paloma Partners first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 4 quarters.
Paloma Partners's AMAG Pharmaceuticals position peaked at $695K in Q4 2016.
113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.

Based on Paloma Partners's 13F filing for Q3 2020, filed 16 Nov 2020.